High dose chemotherapy and stem cell support in a patient of light- and heavy-chain deposition disease with abnormal marrow cell surface antigens and no monoclonal protein

Internal Medicine

Volumn 44, Issue 9, 2005, Pages 970-974

  Sakakima, Masanori ^a   Fujigaki, Yoshihide ^a   Tsuji, Takayuki ^a   Fukasawa, Hirotaka ^a   Miyaji, Takehiko ^a   Naito, Kensuke ^a   Yamamoto, Tatsuo ^a   Yonemura, Katsuhiko ^a   Ohnishi, Kazunori ^a   Hishida, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hemodialysis; Light and heavy chain deposition disease; Marrow cell surface antigens; Monoclonal protein; Peripheral blood stem cell transplantation; Renal failure

Indexed keywords

ANTINEOPLASTIC AGENT; CD19 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CELL SURFACE MARKER; DEXAMETHASONE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MELPHALAN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; PARAPROTEIN; VINCRISTINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUSCULTATION; BONE MARROW CELL; BONE MARROW EXAMINATION; CASE REPORT; CELL CLONE; CLINICAL FEATURE; DISEASE SEVERITY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; GRAFT REJECTION; HEART LEFT VENTRICLE HYPERTROPHY; HEAVY CHAIN DISEASE; HEMATURIA; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; INTESTINE BIOPSY; KIDNEY BIOPSY; KIDNEY FAILURE; LABORATORY TEST; LEG EDEMA; LIGHT AND HEAVY CHAIN DEPOSITION DISEASE; MALE; MEDICAL DECISION MAKING; MEDICAL EXAMINATION; NEPHROTIC SYNDROME; PATIENT REFERRAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHYSICAL EXAMINATION; PLASMA CELL DYSCRASIA; PLASMACYTOSIS; PLEURA EFFUSION; PROTEINURIA; THORAX RADIOGRAPHY; TREATMENT OUTCOME; URINALYSIS;

ANTIGENS, CD19; ANTIGENS, CD56; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; COMBINED MODALITY THERAPY; HEAVY CHAIN DISEASE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PARAPROTEINEMIAS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

EID: 27844564329     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.970     Document Type: Article

References (13)

1. Preud'homme JL, Morel-Maroger L, Brouet JC, Mihaesco E, Mery JP, Seligmann M. Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin. Clin Exp Immunol 42: 545-553, 1980.
2. Preud'homme JL, Aucouturier P, Touchard G, et al. Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains. Kidney Int 46: 965-972, 1994.
3. Lin J, Markowitz GS, Valeri AM, et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol 12: 1482-1492, 2001.
4. Buxbaum JN, Chuba JV, Hellman GC, Solomon A, Gallo GR. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 112: 455-464, 1990.
5. Harada H, Kawano MM, Huang N, et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 81: 2658-2663, 1993.
6. Witzig TE, Li CY, Tefferi A, Katzmann JA. Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemia. Am J Clin Pathol 101: 312-317, 1994.
7. Pozzi C, D'Amico M, Fogazzi GB, et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis 42: 1154-1163, 2003.
8. Ganeval D, Noel LH, Preud'homme JL, Droz D, Grunfeld JP. Light-chain deposition disease: Its relation with AL-type amyloidosis. Kidney Int 26: 1-9, 1984.
9. Komatsuda A, Wakui H, Ohtani H, et al. Disappearance of nodular mesangial lesions in a patient with light chain nephropathy after longterm chemotherapy. Am J Kidney Dis 35: E9, 2000.
10. Child JA, Morgan GJ, Davies FE, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348: 1875-1883, 2003.
11. Skinner M, Sanchorawala. V, Seldin DC, et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study. Ann Intern Med 140: 85-93, 2004.
12. Casserly LF, Fadia A, Sanchorawala V, et al. High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease. Kidney Int 63: 1051-1057, 2003.
13. Royer B, Arnulf B, Martinez F, et al. High dose chemotherapy in light chain or light and heavy chain deposition disease. Kidney Int 65: 642-648, 2004.